According to Guiese et al., there are few studies comparing EN to PN among allo-HSCT patients, although the available evidence shows a clear trend of reduction in the incidence of acute GVHD and low infection-related mortality within the first 100 days after transplant in patients receiving EN. 39 , 40 The only meta-analysis available until today, published in 2008, concluded that there is still insufficient data to determine clear benefits o
← all excerpts
Nutritional status and hyperglycemia in the peritransplant period: a review of associations with parenteral nutrition and clinical outcomes.
1
—
—